LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity.

De Groot, Cornelis Jan / Poitou Bernert, Christine / Coupaye, Muriel / Clement, Karine / Paschou, Stavroula A / Charmandari, Evangelia / Kanaka-Gantenbein, Christina / Wabitsch, Martin / Buddingh, Emilie P / Nieuwenhuijsen, Barbara / Marina, Ljiljana / Johannsson, Gudmundur / Van Den Akker, E L T

Endocrine

2021  Volume 71, Issue 3, Page(s) 653–662

Abstract: ... with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 ... infection, even in case of obesity. Key principals of the obesity management during the pandemic are ... pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g ...

Abstract This article aims to provide guidance on prevention and treatment of COVID-19 in patients with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g., POMC deficiency, PWS); a more severe course in patients with concomitant immunodeficiency (e.g., LEP and LEPR deficiency), although defective leptin signalling could also be protective against the pro-inflammatory phenotype of COVID-19; disease severity being masked by insufficient awareness of symptoms in syndromic obesity patients with intellectual deficit (in particular PWS); to adjust medication dose to increased body size, preferably use dosing in m2; the high risk of malnutrition in patients with Sars-Cov2 infection, even in case of obesity. Key principals of the obesity management during the pandemic are to strive for optimal obesity management and a healthy lifestyle within the possibilities of the regulations to prevent weight (re)gain and to address anxiety within consultations, since prevalence of anxiety for COVID-19 is underestimated.
MeSH term(s) Anxiety ; COVID-19 ; Disease Management ; Healthy Lifestyle ; Humans ; Obesity/epidemiology ; Obesity/genetics ; Obesity/therapy ; Pandemics
Language English
Publishing date 2021-01-29
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID 1194484-5
ISSN 1559-0100 ; 1355-008X ; 0969-711X
ISSN (online) 1559-0100
ISSN 1355-008X ; 0969-711X
DOI 10.1007/s12020-021-02619-y
Shelf mark
Zs.A 3884: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top